Single-cell RNA sequencing in facioscapulohumeral muscular dystrophy disease etiology and development.
Adult
Base Sequence
Cell Nucleus
/ metabolism
Female
Gene Expression Profiling
Gene Expression Regulation
/ genetics
Homeodomain Proteins
/ genetics
Humans
Male
Muscle Cells
Muscle, Skeletal
/ metabolism
Muscular Atrophy
/ genetics
Muscular Dystrophy, Facioscapulohumeral
/ etiology
Primary Cell Culture
Sequence Analysis, RNA
/ methods
Single-Cell Analysis
/ methods
Journal
Human molecular genetics
ISSN: 1460-2083
Titre abrégé: Hum Mol Genet
Pays: England
ID NLM: 9208958
Informations de publication
Date de publication:
01 04 2019
01 04 2019
Historique:
received:
27
08
2018
revised:
12
11
2018
accepted:
13
11
2018
pubmed:
18
11
2018
medline:
2
7
2019
entrez:
17
11
2018
Statut:
ppublish
Résumé
Facioscapulohumeral muscular dystrophy (FSHD) is characterized by sporadic de-repression of the transcription factor DUX4 in skeletal muscle. DUX4 activates a cascade of muscle disrupting events, eventually leading to muscle atrophy and apoptosis. Yet, how sporadic DUX4 expression leads to the generalized muscle wasting remains unclear. Transcriptome analyses have systematically been challenged by the majority of nuclei being DUX4neg, weakening the DUX4 transcriptome signature. Moreover, DUX4 has been shown to be expressed in a highly dynamic burst-like manner, likely resulting in the detection of the downstream cascade of events long after DUX4 expression itself has faded. Identifying the FSHD transcriptome in individual cells and unraveling the cascade of events leading to FSHD development may therefore provide important insights in the disease process. We employed single-cell RNA sequencing, combined with pseudotime trajectory modeling, to study FSHD disease etiology and cellular progression in human primary myocytes. We identified a small FSHD-specific cell population in all tested patient-derived cultures and detected new genes associated with DUX4 de-repression. We furthermore generated an FSHD cellular progression model, reflecting both the early burst-like DUX4 expression as well as the downstream activation of various FSHD-associated pathways, which allowed us to correlate DUX4 expression signature dynamics with that of regulatory complexes, thereby facilitating the prioritization of epigenetic targets for DUX4 silencing. Single-cell transcriptomics combined with pseudotime modeling thus holds valuable information on FSHD disease etiology and progression that can potentially guide biomarker and target selection for therapy.
Identifiants
pubmed: 30445587
pii: 5185122
doi: 10.1093/hmg/ddy400
pmc: PMC6423425
doi:
Substances chimiques
DUX4L1 protein, human
0
Homeodomain Proteins
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1064-1075Subventions
Organisme : NINDS NIH HHS
ID : P01 NS069539
Pays : United States
Informations de copyright
© The Author(s) 2018. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.
Références
Nat Commun. 2018 Feb 23;9(1):789
pubmed: 29476097
PLoS Genet. 2017 Mar 8;13(3):e1006658
pubmed: 28273136
Nat Methods. 2017 Mar;14(3):309-315
pubmed: 28114287
Am J Hum Genet. 2018 Mar 1;102(3):427-446
pubmed: 29499164
Nat Genet. 2017 Jun;49(6):941-945
pubmed: 28459456
Nat Genet. 2017 Jun;49(6):925-934
pubmed: 28459457
Nat Biotechnol. 2014 Apr;32(4):381-386
pubmed: 24658644
J Biol Chem. 2018 Jun 1;293(22):8315-8329
pubmed: 29666189
Hum Mol Genet. 2016 Oct 15;25(20):4419-4431
pubmed: 28171552
Science. 2010 Sep 24;329(5999):1650-3
pubmed: 20724583
Exp Cell Res. 1969 Nov;58(1):163-7
pubmed: 5404063
Dev Cell. 2012 Jan 17;22(1):38-51
pubmed: 22209328
Am J Hum Genet. 2013 Oct 3;93(4):744-51
pubmed: 24075187
Science. 2018 May 18;360(6390):758-763
pubmed: 29622724
Genome Biol. 2017 May 8;18(1):84
pubmed: 28482897
Dev Biol. 1972 Oct;29(2):113-38
pubmed: 4672726
J Cell Sci. 2016 Oct 15;129(20):3816-3831
pubmed: 27744317
Cell. 2016 Aug 25;166(5):1308-1323.e30
pubmed: 27565351
Cell. 2015 Dec 17;163(7):1663-77
pubmed: 26627738
Epigenetics. 2015;10(12):1133-42
pubmed: 26575099
Exp Neurol. 2008 Nov;214(1):87-96
pubmed: 18723017
Elife. 2015 Jan 07;4:
pubmed: 25564732
EMBO J. 2008 Oct 22;27(20):2766-79
pubmed: 18833193
Dis Model Mech. 2017 Oct 1;10(10):1211-1216
pubmed: 28754837
Science. 2016 Apr 8;352(6282):189-96
pubmed: 27124452
Hum Mol Genet. 2014 Oct 15;23(20):5342-52
pubmed: 24861551
Cell. 2002 Aug 9;110(3):339-48
pubmed: 12176321
Skelet Muscle. 2014 Feb 01;4(1):4
pubmed: 24484587
Free Radic Biol Med. 2016 Oct;99:244-258
pubmed: 27519269
Hum Mol Genet. 2003 Nov 15;12(22):2895-907
pubmed: 14519683
Nat Genet. 2012 Dec;44(12):1370-4
pubmed: 23143600
Gene. 2017 Dec 15;636:54-63
pubmed: 28893664
Hum Mol Genet. 2014 Aug 1;23(15):4125-33
pubmed: 24659496
Hum Mol Genet. 2015 Oct 15;24(20):5901-14
pubmed: 26246499
Elife. 2018 Mar 13;7:
pubmed: 29533181
JCI Insight. 2016 Dec 8;1(20):e90558
pubmed: 27942595